Issue navigation
Volume 28, Issue 3, 4 May 2018
Review Article
Clinical practice guideline for Sjögren’s syndrome 2017
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 383–408, https://doi.org/10.1080/14397595.2018.1438093
Antiphospholipid syndrome, “the best prophet of the future”
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 409–416, https://doi.org/10.1080/14397595.2018.1435988
Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 417–431, https://doi.org/10.1080/14397595.2017.1366006
Editorial
Clinical heterogeneity of SAPHO syndrome: Challenge of diagnosis
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 432–434, https://doi.org/10.1080/14397595.2017.1416733
Original Article
Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 435–443, https://doi.org/10.1080/14397595.2017.1366007
Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritis
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 444–451, https://doi.org/10.1080/14397595.2017.1366092
IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 452–460, https://doi.org/10.1080/14397595.2017.1361802
Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 461–467, https://doi.org/10.1080/14397595.2017.1369926
Short-term daily teriparatide in patients with rheumatoid arthritis
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 468–473, https://doi.org/10.1080/14397595.2017.1362093
Characteristics of functional impairment in patients with long-standing rheumatoid arthritis based on range of motion of joints: Baseline data from a multicenter prospective observational cohort study to evaluate the effectiveness of joint surgery in the treat-to-target era
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 474–481, https://doi.org/10.1080/14397595.2017.1349593
Productivity loss of Japanese patients with rheumatoid arthritis – A cross-sectional survey
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 482–489, https://doi.org/10.1080/14397595.2017.1361893
Outcome of the Sauvé–Kapandji procedure for distal radioulnar joint disorder with rheumatoid arthritis or osteoarthritis: Results of one-year follow-up
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 490–494, https://doi.org/10.1080/14397595.2017.1366005
Mithramycin has inhibitory effects on gliostatin and matrix metalloproteinase expression induced by gliostatin in rheumatoid fibroblast-like synoviocytes
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 495–505, https://doi.org/10.1080/14397595.2017.1350332
Differential influences of Fc gamma receptor blocking on the effects of certolizumab pegol and infliximab on human monocytes
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 506–512, https://doi.org/10.1080/14397595.2017.1354796
TNF-α potentiates uric acid-induced interleukin-1β (IL-1β) secretion in human neutrophils
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 513–517, https://doi.org/10.1080/14397595.2017.1369924
Are there risk factors for scleroderma-related calcinosis?
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 518–522, https://doi.org/10.1080/14397595.2017.1349594
Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 523–529, https://doi.org/10.1080/14397595.2017.1352479
The effect and possible clinical efficacy of in vivo inhibition of neutrophil extracellular traps by blockade of PI3K-gamma on the pathogenesis of microscopic polyangiitis
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 530–541, https://doi.org/10.1080/14397595.2017.1367116
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 542–549, https://doi.org/10.1080/14397595.2017.1367076
Case Report
A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 550–554, https://doi.org/10.3109/14397595.2015.1115160
Immunoglobulin G4-positive lymphoplasmacytic infiltration in a sarcoidal eyelid mass
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 555–558, https://doi.org/10.3109/14397595.2015.1118791
Diffuse large B-cell lymphoma of the lacrimal sac arising from a patient with IgG4-related disease
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 559–563, https://doi.org/10.3109/14397595.2015.1131353
TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 564–569, https://doi.org/10.3109/14397595.2015.1120389
Cryoglobulinemic vasculitis with primary Sjögren’s syndrome: A case report
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 570–574, https://doi.org/10.3109/14397595.2015.1128870
Letter
The efficacy of abatacept focusing on anti-CCP antibody in Japanese patients with rheumatoid arthritis for 104 weeks
Modern Rheumatology, Volume 28, Issue 3, 4 May 2018, Pages 575–577, https://doi.org/10.1080/14397595.2017.1365805
